Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1995The Journal of Experimental Medicine

PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLiu HSouthwest Petroleum UniversityZMZ M MuJiangnan UniversityKCK S ChangThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

H et al. (1995) studied this question.

synapsesocial.com/papers/6a8534ea4b2893ddcbc6b2ddhttps://doi.org/10.1084/jem.181.6.1965
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PML, a growth suppressor disrupted in acute promyelocytic leukemia.1994 · 293 citations
  2. 2Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia1988 · 2,512 citations
  3. 3Redesign of Retrovirus Packaging Cell Lines To Avoid Recombination Leading to Helper Virus Production1986 · 1,251 citations
  4. 4NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)1991 · 891 citations
  5. 5Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.1991 · 85 citations